Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02306291
Title Study to Determine Safety, Pharmacokinetics and Efficacy of GMI-1271 in Combination With Chemotherapy in AML
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors GlycoMimetics Incorporated
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | AUS

Facility Status City State Zip Country Details
University of California, Davis Comprehensive Cancer Center Sacramento California 95817 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02115 United States Details
University of Michigan, Ann Arbor Ann Arbor Michigan 48109 United States Details
University of Rochester Rochester New York 14642 United States Details
Cleveland Clinic Cleveland Ohio 44195 United States Details
University of Washington Seattle Washington 98109 United States Details
Princess Alexandra Hospital Brisbane Australia Details
University Hospital Galway Galway Ireland Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field